NEW YORK, July 18 – Third Wave Agbio said Wednesday that Valigen has agreed to use its Invader SNP analysis platform to study genetic variations in plants.

As part of its research into developing agricultural products with improved traits, Valigen, headquartered in Paris-la-Defense, France, will use Third Wave Agbio’s technology to detect genetic changes in plants modified using Valigen’s Genoplasty technology. 

Financial details of the deal were not disclosed. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.